Conventional diagnostic approaches for ovarian cancer using transvaginal ultrasonography and serum levels of cancer antigen-125 (CA-125) or/and human epididymis protein (HE-4), the protein-based biomarkers for OC, have not been shown to reduce its mortality [6]. This evidence concerns the gene MUC16 and ovarian cancer.